Global Cancer Ablation Devices Market Growth 2020-2025


Apr, 2020 | Report ID: 136422 | 166 | Medical Devices

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Cancer Ablation Devices will have significant change from previous year. By the most conservative estimates of global Cancer Ablation Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Cancer Ablation Devices market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Ablation Devices market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Cancer Ablation Devices, covering the supply chain analysis, impact assessment to the Cancer Ablation Devices market size growth rate in several scenarios, and the measures to be undertaken by Cancer Ablation Devices companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Cryoablation

High-Intensity Focused Ultrasound (HIFU)

Laser Interstitial Thermal Therapy (LiTT)

Microwave Ablation (MWA)

Radiofrequency Ablation (RFA)

Irreversible Electroporation (Ire)

Non-Thermal Ablation

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Brain Cancer

Brown

Colorectal Cancer

Kidney Cancer

Liver Cancer

Lung Cancer

Pancreatic Cancer

Prostate Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Alfresa Pharma Corp.

HS Hospital Service S.p.A.

AngioDynamics, Inc.

Biomedical S.r.l.

Boston Scientific Corporation

BTG plc (Galil Medical Ltd./Perseon Medical)

ECO Medical

CSA Medical, Inc.

EDAP TMS S.A.

Chongqing Haifu Medical Technology Co., Ltd

IceCure Medical, Inc.

MedLink Technologies LLC

Kang-Yu Medical Co., Ltd.

MedWaves, Inc.

Johnson & Johnson (Ethicon, Inc.)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Cancer Ablation Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Cancer Ablation Devices market by identifying its various subsegments.

Focuses on the key global Cancer Ablation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cancer Ablation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Cancer Ablation Devices submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

1.8 What is the Impact of Covid-19 Outbreak On the Cancer Ablation Devices?

1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cancer Ablation Devices Market Size in 2020, by Scenario

1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Ablation Devices Consumption 2015-2025

2.1.2 Cancer Ablation Devices Consumption CAGR by Region

2.2 Cancer Ablation Devices Segment by Type

2.2.1 Cryoablation

2.2.2 High-Intensity Focused Ultrasound (HIFU)

2.2.3 Laser Interstitial Thermal Therapy (LiTT)

2.2.4 Microwave Ablation (MWA)

2.2.5 Radiofrequency Ablation (RFA)

2.2.6 Irreversible Electroporation (Ire)

2.2.7 Non-Thermal Ablation

2.3 Cancer Ablation Devices Consumption by Type

2.3.1 Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

2.3.2 Global Cancer Ablation Devices Revenue and Market Share by Type (2015-2020)

2.3.3 Global Cancer Ablation Devices Sale Price by Type (2015-2020)

2.4 Cancer Ablation Devices Segment by Application

2.4.1 Brain Cancer

2.4.2 Brown

2.4.3 Colorectal Cancer

2.4.4 Kidney Cancer

2.4.5 Liver Cancer

2.4.6 Lung Cancer

2.4.7 Pancreatic Cancer

2.4.8 Prostate Cancer

2.5 Cancer Ablation Devices Consumption by Application

2.5.1 Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

2.5.2 Global Cancer Ablation Devices Value and Market Share by Type (2015-2020)

2.5.3 Global Cancer Ablation Devices Sale Price by Type (2015-2020)

3 Global Cancer Ablation Devices by Company

3.1 Global Cancer Ablation Devices Sales Market Share by Company

3.1.1 Global Cancer Ablation Devices Sales by Company (2018-2020)

3.1.2 Global Cancer Ablation Devices Sales Market Share by Company (2018-2020)

3.2 Global Cancer Ablation Devices Revenue Market Share by Company

3.2.1 Global Cancer Ablation Devices Revenue by Company (2018-2020)

3.2.2 Global Cancer Ablation Devices Revenue Market Share by Company (2018-2020)

3.3 Global Cancer Ablation Devices Sale Price by Company

3.4 Global Cancer Ablation Devices Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Cancer Ablation Devices Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Cancer Ablation Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Cancer Ablation Devices by Regions

4.1 Cancer Ablation Devices by Regions

4.2 Americas Cancer Ablation Devices Consumption Growth

4.3 APAC Cancer Ablation Devices Consumption Growth

4.4 Europe Cancer Ablation Devices Consumption Growth

4.5 Middle East & Africa Cancer Ablation Devices Consumption Growth

5 Americas

5.1 Americas Cancer Ablation Devices Consumption by Countries

5.1.1 Americas Cancer Ablation Devices Consumption by Countries (2015-2020)

5.1.2 Americas Cancer Ablation Devices Value by Countries (2015-2020)

5.2 Americas Cancer Ablation Devices Consumption by Type

5.3 Americas Cancer Ablation Devices Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cancer Ablation Devices Consumption by Regions

6.1.1 APAC Cancer Ablation Devices Consumption by Regions (2015-2020)

6.1.2 APAC Cancer Ablation Devices Value by Regions (2015-2020)

6.2 APAC Cancer Ablation Devices Consumption by Type

6.3 APAC Cancer Ablation Devices Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Cancer Ablation Devices by Countries

7.1.1 Europe Cancer Ablation Devices Consumption by Countries (2015-2020)

7.1.2 Europe Cancer Ablation Devices Value by Countries (2015-2020)

7.2 Europe Cancer Ablation Devices Consumption by Type

7.3 Europe Cancer Ablation Devices Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Cancer Ablation Devices by Countries

8.1.1 Middle East & Africa Cancer Ablation Devices Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Cancer Ablation Devices Value by Countries (2015-2020)

8.2 Middle East & Africa Cancer Ablation Devices Consumption by Type

8.3 Middle East & Africa Cancer Ablation Devices Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Cancer Ablation Devices Distributors

10.3 Cancer Ablation Devices Customer

11 Global Cancer Ablation Devices Market Forecast

11.1 Global Cancer Ablation Devices Consumption Forecast (2021-2025)

11.2 Global Cancer Ablation Devices Forecast by Regions

11.2.1 Global Cancer Ablation Devices Forecast by Regions (2021-2025)

11.2.2 Global Cancer Ablation Devices Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Cancer Ablation Devices Forecast by Type

11.8 Global Cancer Ablation Devices Forecast by Application

12 Key Players Analysis

12.1 Alfresa Pharma Corp.

12.1.1 Company Information

12.1.2 Cancer Ablation Devices Product Offered

12.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Alfresa Pharma Corp. Latest Developments

12.2 HS Hospital Service S.p.A.

12.2.1 Company Information

12.2.2 Cancer Ablation Devices Product Offered

12.2.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 HS Hospital Service S.p.A. Latest Developments

12.3 AngioDynamics, Inc.

12.3.1 Company Information

12.3.2 Cancer Ablation Devices Product Offered

12.3.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 AngioDynamics, Inc. Latest Developments

12.4 Biomedical S.r.l.

12.4.1 Company Information

12.4.2 Cancer Ablation Devices Product Offered

12.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Biomedical S.r.l. Latest Developments

12.5 Boston Scientific Corporation

12.5.1 Company Information

12.5.2 Cancer Ablation Devices Product Offered

12.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Boston Scientific Corporation Latest Developments

12.6 BTG plc (Galil Medical Ltd./Perseon Medical)

12.6.1 Company Information

12.6.2 Cancer Ablation Devices Product Offered

12.6.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments

12.7 ECO Medical

12.7.1 Company Information

12.7.2 Cancer Ablation Devices Product Offered

12.7.3 ECO Medical Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 ECO Medical Latest Developments

12.8 CSA Medical, Inc.

12.8.1 Company Information

12.8.2 Cancer Ablation Devices Product Offered

12.8.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 CSA Medical, Inc. Latest Developments

12.9 EDAP TMS S.A.

12.9.1 Company Information

12.9.2 Cancer Ablation Devices Product Offered

12.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 EDAP TMS S.A. Latest Developments

12.10 Chongqing Haifu Medical Technology Co., Ltd

12.10.1 Company Information

12.10.2 Cancer Ablation Devices Product Offered

12.10.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Chongqing Haifu Medical Technology Co., Ltd Latest Developments

12.11 IceCure Medical, Inc.

12.11.1 Company Information

12.11.2 Cancer Ablation Devices Product Offered

12.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 IceCure Medical, Inc. Latest Developments

12.12 MedLink Technologies LLC

12.12.1 Company Information

12.12.2 Cancer Ablation Devices Product Offered

12.12.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 MedLink Technologies LLC Latest Developments

12.13 Kang-Yu Medical Co., Ltd.

12.13.1 Company Information

12.13.2 Cancer Ablation Devices Product Offered

12.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Kang-Yu Medical Co., Ltd. Latest Developments

12.14 MedWaves, Inc.

12.14.1 Company Information

12.14.2 Cancer Ablation Devices Product Offered

12.14.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 MedWaves, Inc. Latest Developments

12.15 Johnson & Johnson (Ethicon, Inc.)

12.15.1 Company Information

12.15.2 Cancer Ablation Devices Product Offered

12.15.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Johnson & Johnson (Ethicon, Inc.) Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cancer Ablation Devices Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Cancer Ablation Devices Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Cancer Ablation Devices Consumption CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of Cryoablation

Table 7. Major Players of High-Intensity Focused Ultrasound (HIFU)

Table 8. Major Players of Laser Interstitial Thermal Therapy (LiTT)

Table 9. Major Players of Microwave Ablation (MWA)

Table 10. Major Players of Radiofrequency Ablation (RFA)

Table 11. Major Players of Irreversible Electroporation (Ire)

Table 12. Major Players of Non-Thermal Ablation

Table 13. Global Consumption Sales by Type (2015-2020)

Table 14. Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Table 15. Global Cancer Ablation Devices Revenue by Type (2015-2020) ($ million)

Table 16. Global Cancer Ablation Devices Value Market Share by Type (2015-2020) ($ Millions)

Table 17. Global Cancer Ablation Devices Sale Price by Type (2015-2020)

Table 18. Global Consumption Sales by Application (2015-2020)

Table 19. Global Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Table 20. Global Cancer Ablation Devices Value by Application (2015-2020)

Table 21. Global Cancer Ablation Devices Value Market Share by Application (2015-2020)

Table 22. Global Cancer Ablation Devices Sale Price by Application (2015-2020)

Table 23. Global Cancer Ablation Devices Sales by Company (2017-2019) (K Units)

Table 24. Global Cancer Ablation Devices Sales Market Share by Company (2017-2019)

Table 25. Global Cancer Ablation Devices Revenue by Company (2017-2019) ($ Millions)

Table 26. Global Cancer Ablation Devices Revenue Market Share by Company (2017-2019)

Table 27. Global Cancer Ablation Devices Sale Price by Company (2017-2019)

Table 28. Global Cancer Ablation Devices Manufacturing Base Distribution and Sales Area by Manufacturers

Table 29. Players Cancer Ablation Devices Products Offered

Table 30. Cancer Ablation Devices Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 31. Global Cancer Ablation Devices Consumption by Regions 2015-2020 (K Units)

Table 32. Global Cancer Ablation Devices Consumption Market Share by Regions 2015-2020

Table 33. Global Cancer Ablation Devices Value by Regions 2015-2020 ($ Millions)

Table 34. Global Cancer Ablation Devices Value Market Share by Regions 2015-2020

Table 35. Americas Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)

Table 36. Americas Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)

Table 37. Americas Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)

Table 38. Americas Cancer Ablation Devices Value Market Share by Countries (2015-2020)

Table 39. Americas Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)

Table 40. Americas Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Table 41. Americas Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)

Table 42. Americas Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Table 43. APAC Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)

Table 44. APAC Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)

Table 45. APAC Cancer Ablation Devices Value by Regions (2015-2020) ($ Millions)

Table 46. APAC Cancer Ablation Devices Value Market Share by Regions (2015-2020)

Table 47. APAC Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)

Table 48. APAC Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Table 49. APAC Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)

Table 50. APAC Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Table 51. Europe Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)

Table 52. Europe Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)

Table 53. Europe Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)

Table 54. Europe Cancer Ablation Devices Value Market Share by Countries (2015-2020)

Table 55. Europe Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)

Table 56. Europe Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Table 57. Europe Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)

Table 58. Europe Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Table 59. Middle East & Africa Cancer Ablation Devices Consumption by Countries (2015-2020) (K Units)

Table 60. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Countries (2015-2020)

Table 61. Middle East & Africa Cancer Ablation Devices Value by Countries (2015-2020) ($ Millions)

Table 62. Middle East & Africa Cancer Ablation Devices Value Market Share by Countries (2015-2020)

Table 63. Middle East & Africa Cancer Ablation Devices Consumption by Type (2015-2020) (K Units)

Table 64. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Table 65. Middle East & Africa Cancer Ablation Devices Consumption by Application (2015-2020) (K Units)

Table 66. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Table 67. Cancer Ablation Devices Distributors List

Table 68. Cancer Ablation Devices Customer List

Table 69. Global Cancer Ablation Devices Consumption Forecast by Countries (2021-2025) (K Units)

Table 70. Global Cancer Ablation Devices Consumption Market Forecast by Regions

Table 71. Global Cancer Ablation Devices Value Forecast by Countries (2021-2025) ($ Millions)

Table 72. Global Cancer Ablation Devices Value Market Share Forecast by Regions

Table 73. Global Cancer Ablation Devices Consumption Forecast by Type (2021-2025) (K Units)

Table 74. Global Cancer Ablation Devices Consumption Market Share Forecast by Type (2021-2025)

Table 75. Global Cancer Ablation Devices Value Forecast by Type (2021-2025) ($ Millions)

Table 76. Global Cancer Ablation Devices Value Market Share Forecast by Type (2021-2025)

Table 77. Global Cancer Ablation Devices Consumption Forecast by Application (2021-2025) (K Units)

Table 78. Global Cancer Ablation Devices Consumption Market Share Forecast by Application (2021-2025)

Table 79. Global Cancer Ablation Devices Value Forecast by Application (2021-2025) ($ Millions)

Table 80. Global Cancer Ablation Devices Value Market Share Forecast by Application (2021-2025)

Table 81. Alfresa Pharma Corp. Product Offered

Table 82. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 83. Alfresa Pharma Corp. Main Business

Table 84. Alfresa Pharma Corp. Latest Developments

Table 85. Alfresa Pharma Corp. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 86. HS Hospital Service S.p.A. Product Offered

Table 87. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 88. HS Hospital Service S.p.A. Main Business

Table 89. HS Hospital Service S.p.A. Latest Developments

Table 90. HS Hospital Service S.p.A. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 91. AngioDynamics, Inc. Product Offered

Table 92. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 93. AngioDynamics, Inc. Main Business

Table 94. AngioDynamics, Inc. Latest Developments

Table 95. AngioDynamics, Inc. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 96. Biomedical S.r.l. Product Offered

Table 97. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 98. Biomedical S.r.l. Main Business

Table 99. Biomedical S.r.l. Latest Developments

Table 100. Biomedical S.r.l. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 101. Boston Scientific Corporation Product Offered

Table 102. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 103. Boston Scientific Corporation Main Business

Table 104. Boston Scientific Corporation Latest Developments

Table 105. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 106. BTG plc (Galil Medical Ltd./Perseon Medical) Product Offered

Table 107. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 108. BTG plc (Galil Medical Ltd./Perseon Medical) Main Business

Table 109. BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments

Table 110. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 111. ECO Medical Product Offered

Table 112. ECO Medical Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 113. ECO Medical Main Business

Table 114. ECO Medical Latest Developments

Table 115. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 116. CSA Medical, Inc. Product Offered

Table 117. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 118. CSA Medical, Inc. Main Business

Table 119. CSA Medical, Inc. Latest Developments

Table 120. CSA Medical, Inc. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 121. EDAP TMS S.A. Product Offered

Table 122. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 123. EDAP TMS S.A. Main Business

Table 124. EDAP TMS S.A. Latest Developments

Table 125. EDAP TMS S.A. Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 126. Chongqing Haifu Medical Technology Co., Ltd Product Offered

Table 127. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 128. Chongqing Haifu Medical Technology Co., Ltd Main Business

Table 129. Chongqing Haifu Medical Technology Co., Ltd Latest Developments

Table 130. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Company Total Revenue (in $ million), Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 131. IceCure Medical, Inc. Product Offered

Table 132. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 133. IceCure Medical, Inc. Main Business

Table 134. IceCure Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 135. IceCure Medical, Inc. Latest Developments

Table 136. MedLink Technologies LLC Product Offered

Table 137. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 138. MedLink Technologies LLC Main Business

Table 139. MedLink Technologies LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 140. MedLink Technologies LLC Latest Developments

Table 141. Kang-Yu Medical Co., Ltd. Product Offered

Table 142. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 143. Kang-Yu Medical Co., Ltd. Main Business

Table 144. Kang-Yu Medical Co., Ltd. Latest Developments

Table 145. Kang-Yu Medical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 146. MedWaves, Inc. Product Offered

Table 147. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 148. MedWaves, Inc. Main Business

Table 149. MedWaves, Inc. Latest Developments

Table 150. MedWaves, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 151. Johnson & Johnson (Ethicon, Inc.) Product Offered

Table 152. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 153. Johnson & Johnson (Ethicon, Inc.) Main Business

Table 154. Johnson & Johnson (Ethicon, Inc.) Latest Developments

Table 155. Johnson & Johnson (Ethicon, Inc.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Cancer Ablation Devices

Figure 2. Cancer Ablation Devices Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Cancer Ablation Devices Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Cancer Ablation Devices Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Cryoablation

Figure 7. Product Picture of High-Intensity Focused Ultrasound (HIFU)

Figure 8. Product Picture of Laser Interstitial Thermal Therapy (LiTT)

Figure 9. Product Picture of Microwave Ablation (MWA)

Figure 10. Product Picture of Radiofrequency Ablation (RFA)

Figure 11. Product Picture of Irreversible Electroporation (Ire)

Figure 12. Product Picture of Non-Thermal Ablation

Figure 13. Global Cancer Ablation Devices Consumption Market Share by Type (2015-2020)

Figure 14. Global Cancer Ablation Devices Value Market Share by Type (2015-2020)

Figure 15. Cancer Ablation Devices Consumed in Brain Cancer

Figure 16. Global Cancer Ablation Devices Market: Brain Cancer (2015-2020) (K Units)

Figure 17. Global Cancer Ablation Devices Market: Brain Cancer (2015-2020) ($ Millions)

Figure 18. Cancer Ablation Devices Consumed in Brown

Figure 19. Global Cancer Ablation Devices Market: Brown (2015-2020) (K Units)

Figure 20. Global Cancer Ablation Devices Market: Brown (2015-2020) ($ Millions)

Figure 21. Cancer Ablation Devices Consumed in Colorectal Cancer

Figure 22. Global Cancer Ablation Devices Market: Colorectal Cancer (2015-2020) (K Units)

Figure 23. Global Cancer Ablation Devices Market: Colorectal Cancer (2015-2020) ($ Millions)

Figure 24. Cancer Ablation Devices Consumed in Kidney Cancer

Figure 25. Global Cancer Ablation Devices Market: Kidney Cancer (2015-2020) (K Units)

Figure 26. Global Cancer Ablation Devices Market: Kidney Cancer (2015-2020) ($ Millions)

Figure 27. Cancer Ablation Devices Consumed in Liver Cancer

Figure 28. Global Cancer Ablation Devices Market: Liver Cancer (2015-2020) (K Units)

Figure 29. Global Cancer Ablation Devices Market: Liver Cancer (2015-2020) ($ Millions)

Figure 30. Cancer Ablation Devices Consumed in Lung Cancer

Figure 31. Cancer Ablation Devices Consumed in Pancreatic Cancer

Figure 32. Cancer Ablation Devices Consumed in Prostate Cancer

Figure 33. Global Cancer Ablation Devices Consumption Market Share by Application (2015-2020)

Figure 34. Global Cancer Ablation Devices Value Market Share by Application (2015-2020)

Figure 35. Global Cancer Ablation Devices Sales Market Share by Company in 2017

Figure 36. Global Cancer Ablation Devices Sales Market Share by Company in 2019

Figure 37. Global Cancer Ablation Devices Revenue Market Share by Company in 2017

Figure 38. Global Cancer Ablation Devices Revenue Market Share by Company in 2019

Figure 39. Global Cancer Ablation Devices Sale Price by Company in 2019

Figure 40. Global Cancer Ablation Devices Consumption Market Share by Regions 2015-2020

Figure 41. Global Cancer Ablation Devices Value Market Share by Regions 2015-2020

Figure 42. Americas Cancer Ablation Devices Consumption 2015-2020 (K Units)

Figure 43. Americas Cancer Ablation Devices Value 2015-2020 ($ Millions)

Figure 44. APAC Cancer Ablation Devices Consumption 2015-2020 (K Units)

Figure 45. APAC Cancer Ablation Devices Value 2015-2020 ($ Millions)

Figure 46. Europe Cancer Ablation Devices Consumption 2015-2020 (K Units)

Figure 47. Europe Cancer Ablation Devices Value 2015-2020 ($ Millions)

Figure 48. Middle East & Africa Cancer Ablation Devices Consumption 2015-2020 (K Units)

Figure 49. Middle East & Africa Cancer Ablation Devices Value 2015-2020 ($ Millions)

Figure 50. Americas Cancer Ablation Devices Consumption Market Share by Countries in 2019

Figure 51. Americas Cancer Ablation Devices Value Market Share by Countries in 2019

Figure 52. Americas Cancer Ablation Devices Consumption Market Share by Type in 2019

Figure 53. Americas Cancer Ablation Devices Consumption Market Share by Application in 2019

Figure 54. United States Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 55. United States Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 56. Canada Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 57. Canada Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 58. Mexico Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 59. Mexico Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 60. APAC Cancer Ablation Devices Consumption Market Share by Countries in 2019

Figure 61. APAC Cancer Ablation Devices Value Market Share by Regions in 2019

Figure 62. APAC Cancer Ablation Devices Consumption Market Share by Type in 2019

Figure 63. APAC Cancer Ablation Devices Consumption Market Share by Application in 2019

Figure 64. China Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 65. China Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 66. Japan Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 67. Japan Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 68. Korea Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 69. Korea Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 70. Southeast Asia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 71. Southeast Asia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 72. India Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 73. India Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 74. Australia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 75. Australia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 76. Europe Cancer Ablation Devices Consumption Market Share by Countries in 2019

Figure 77. Europe Cancer Ablation Devices Value Market Share by Countries in 2019

Figure 78. Europe Cancer Ablation Devices Consumption Market Share by Type in 2019

Figure 79. Europe Cancer Ablation Devices Consumption Market Share by Application in 2019

Figure 80. Germany Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 81. Germany Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 82. France Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 83. France Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 84. UK Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 85. UK Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 86. Italy Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 87. Italy Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 88. Russia Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 89. Russia Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 90. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Countries in 2019

Figure 91. Middle East & Africa Cancer Ablation Devices Value Market Share by Countries in 2019

Figure 92. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Type in 2019

Figure 93. Middle East & Africa Cancer Ablation Devices Consumption Market Share by Application in 2019

Figure 94. Egypt Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 95. Egypt Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 96. South Africa Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 97. South Africa Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 98. Israel Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 99. Israel Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 100. Turkey Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 101. Turkey Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 102. GCC Countries Cancer Ablation Devices Consumption Growth 2015-2020 (K Units)

Figure 103. GCC Countries Cancer Ablation Devices Value Growth 2015-2020 ($ Millions)

Figure 104. Global Cancer Ablation Devices Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 105. Global Cancer Ablation Devices Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 106. Americas Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 107. Americas Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 108. APAC Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 109. APAC Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 110. Europe Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 111. Europe Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 112. Middle East & Africa Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 113. Middle East & Africa Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 114. United States Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 115. United States Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 116. Canada Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 117. Canada Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 118. Mexico Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 119. Mexico Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 120. Brazil Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 121. Brazil Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 122. China Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 123. China Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 124. Japan Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 125. Japan Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 126. Korea Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 127. Korea Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 128. Southeast Asia Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 129. Southeast Asia Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 130. India Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 131. India Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 132. Australia Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 133. Australia Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 134. Germany Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 135. Germany Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 136. France Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 137. France Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 138. UK Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 139. UK Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 140. Italy Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 141. Italy Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 142. Russia Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 143. Russia Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 144. Spain Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 145. Spain Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 146. Egypt Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 147. Egypt Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 148. South Africa Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 149. South Africa Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 150. Israel Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 151. Israel Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 152. Turkey Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 153. Turkey Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 154. GCC Countries Cancer Ablation Devices Consumption 2021-2025 (K Units)

Figure 155. GCC Countries Cancer Ablation Devices Value 2021-2025 ($ Millions)

Figure 156. Alfresa Pharma Corp. Cancer Ablation Devices Market Share (2018-2020)

Figure 157. HS Hospital Service S.p.A. Cancer Ablation Devices Market Share (2018-2020)

Figure 158. AngioDynamics, Inc. Cancer Ablation Devices Market Share (2018-2020)

Figure 159. Biomedical S.r.l. Cancer Ablation Devices Market Share (2018-2020)

Figure 160. Boston Scientific Corporation Cancer Ablation Devices Market Share (2018-2020)

Figure 161. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Market Share (2018-2020)

Figure 162. ECO Medical Cancer Ablation Devices Market Share (2018-2020)

Figure 163. CSA Medical, Inc. Cancer Ablation Devices Market Share (2018-2020)

Figure 164. EDAP TMS S.A. Cancer Ablation Devices Market Share (2018-2020)

Figure 165. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Market Share (2018-2020)

Figure 166. IceCure Medical, Inc. Cancer Ablation Devices Market Share (2018-2020)

Figure 167. MedLink Technologies LLC Cancer Ablation Devices Market Share (2018-2020)

Figure 168. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Market Share (2018-2020)

Figure 169. MedWaves, Inc. Cancer Ablation Devices Market Share (2018-2020)

Figure 170. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Market Share (2018-2020)

Sample Request is not available